Healthyvibes Healthcare

ibsovo (ivosidenib) is a targeted therapy that’s used to treat adults with acute myeloid leukemia (AML) or bile duct cancer (cholangiocarcinoma). It’s used only in people who have the IDH1 mutation in their cancer. Tibsovo (ivosidenib) is a convenient option because it’s a tablet that you take by mouth. But it can cause side effects like diarrhea, tiredness, and changes in heart rhythm. This medication can also cause a serious reaction called differentiation syndrome in people getting treated for AML.

Alectinib is used to treat a certain type of lung cancer. It works by slowing or stopping the growth of cancer cells. Alectinib belongs to a class of drugs known as tyrosine kinase inhibitors.

You usually keep taking tucatinib, trastuzumab and capecitabine for as long as they work or until the side effects get too bad. You take tucatinib as tablets that you swallow twice a day 12 hours apart (morning and evening).

Palboxen 125mg Capsule is used to treat patients with certain types of breast cancer (estrogen receptor-positive, human epidermal growth factor receptor 2-negative) which have spread to other organs. It is given together with hormonal anticancer therapies.

Neratinib is a type of targeted cancer drug. It is pronounced ne-rat-ti-nib. It is also known as Nerlynx. You have tests on your breast cancer cells to check for these.

This medication is used to treat lung cancer. Osimertinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells.

Our strict adherence to cGMP and relentless efforts to achieve the best quality standard with our exclusive people and process help us provide the finest products to improve the quality of life.

Our strict adherence to cGMP and relentless efforts to achieve the best quality standard with our exclusive people and process help us provide the finest products to improve the quality of life.

Olaparib 50mg Capsules is used to treat advanced ovarian cancer (with deleterious germline BRCA mutated (gBRCAm) as detected by an FDA-approved test) who have been treated with three or more prior lines of chemotherapy. Also been used to treat HER2-negative metastatic breast cancer (with deleterious or suspected gBRCAm), who have been treated with chemotherapy. Generic Olaparib is a targeted therapy. Olaparib is a poly (ADP-ribose) polymerase (PARP) enzyme inhibitor, including PARP1, PARP2, and PARP3. PARP enzymes are involved in DNA transcription, cell cycle regulation, and DNA repair. Olaparib is a potent oral PARP inhibitor which induces synthetic lethality in BRCA 1/2 deficient tumor cells through the formation of double-stranded DNA breaks which cannot be accurately repaired, which leads to disruption of cellular homeostasis and cell death.

Selpercatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) in adults that has spread to nearby tissues or other parts of the body.

Velpanex 400 mg + 100 mg Tablet generic name is Sofosbuvir + Velpatasvir. Velpanex 400 mg + 100 mg Tablet is manufactured by Everest Pharmaceuticals Ltd.Velpanex is availble in all over Bangladesh.

Lenvatinib is used to treat progressive, differentiated thyroid cancer that can no longer be treated with radioactive iodine and has already spread to different parts of the body.1 Jun 2024

This medication is an antidopaminergic agent, used in treating nausea, vomiting, gastrointestinal problems and Parkinson's disease.

INDICATIONS AND USAGE EXKIVITY is indicated for the treatment of adult patients with locally advanced or metastatic nonsmall cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test [see Dosage and Administration (2.1)], whose disease has progressed on or after platinum-based chemotherapy. This indication is approved under accelerated approval based on overall response rate and duration of response [see Clinical Studies (14)]. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trial(s). 2 DOSAGE AND ADMINISTRATION 2.1 Patient Selection Select patients with locally advanced or metastatic NSCLC for treatment with EXKIVITY based on the presence of EGFR exon 20 insertion mutations